Thomas Wan

Biography

Thomas Wan is currently the Cytogeneticist in charge and Honorary Associate Professor of the Department of Pathology, Queen Mary Hospital, University of Hong Kong, Hong Kong. He is also the Visiting Professor of the Fujian Medical University and Honorary Professor of the Harbin Medical University, China. Dr Wan was born in Hong Kong and obtained his Bachelor of Science in Medical Technology from the National Taiwan University, Taiwan in 1984. He obtained his Master of Philosophy and Doctor of Philosophy degrees at the University of Hong Kong in 1992 and 1997 respectively. Dr Wan is one of the most experienced cancer cytogeneticist in Hong Kong.  He is certainly the best qualified as well as the most prolific. Dr Wan has been awarded the Membership of the Royal College of Pathologists of the UK (specialized in Clinical Cytogenetics) based on published works in 2003. This achievement is no small feat and is one that is bestowed to basic and clinical scientists whose work is considered of the highest calibre.  He was awarded the Fellowship of the Royal College of Pathologists in 2008.  Dr Wan has been attached to several laboratories in the USA and Canada for research training, including Harvard Medical School, University of British Columbia, and the California Institute of Biological Research.  He has been chosen by Cold Spring Harbor Laboratory (USA) to attend advanced molecular cytogenetics courses. He is now considered one of the regional experts on molecular cytogenetics procedures.  He has frequently been invited to deliver lectures at academic institutions and scientific conferences in Asia. Dr Wan is the scientific advisor and consultant in many institutions and the HKSAR government. Furthermore, he serves in the editorial board of the International Journal of Oncology, Journal of the Association of Genetic Technologists, Atlas of Genetics and Cytogenetics in Oncology and Haematology. To date, he has authored more than 120 reports, reviews and on-line publications in international peer reviewed journals. Thomas Wan is currently the Cytogeneticist in charge and Honorary Associate Professor of the Department of Pathology, Queen Mary Hospital, University of Hong Kong, Hong Kong. He is also the Visiting Professor of the Fujian Medical University and Honorary Professor of the Harbin Medical University, China. Dr Wan was born in Hong Kong and obtained his Bachelor of Science in Medical Technology from the National Taiwan University, Taiwan in 1984. He obtained his Master of Philosophy and Doctor of Philosophy degrees at the University of Hong Kong in 1992 and 1997 respectively. Dr Wan is one of the most experienced cancer cytogeneticist in Hong Kong.  He is certainly the best qualified as well as the most prolific. Dr Wan has been awarded the Membership of the Royal College of Pathologists of the UK (specialized in Clinical Cytogenetics) based on published works in 2003. This achievement is no small feat and is one that is bestowed to basic and clinical scientists whose work is considered of the highest calibre.  He was awarded the Fellowship of the Royal College of Pathologists in 2008.  Dr Wan has been attached to several laboratories in the USA and Canada for research training, including Harvard Medical School, University of British Columbia, and the California Institute of Biological Research.  He has been chosen by Cold Spring Harbor Laboratory (USA) to attend advanced molecular cytogenetics courses. He is now considered one of the regional experts on molecular cytogenetics procedures.  He has frequently been invited to deliver lectures at academic institutions and scientific conferences in Asia. Dr Wan is the scientific advisor and consultant in many institutions and the HKSAR government. Furthermore, he serves in the editorial board of the International Journal of Oncology, Journal of the Association of Genetic Technologists, Atlas of Genetics and Cytogenetics in Oncology and Haematology. To date, he has authored more than 120 reports, reviews and on-line publications in international peer reviewed journals.

Research Interest

Study of hematological malignancies and pediatric solid tumours, especially on the genesis of the chromosomal aberrations in tumorogenesis.